BridgeMD
New treatment option for Shoulder Tendinopathy
Official title PEMF Therapy in Shoulder Tendinopathy
ClinicalTrials.gov ID: NCT07550543
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate whether pulsed electromagnetic field (PEMF) therapy delivered via the Super Inductive System (SIS), integrated into a multimodal rehabilitation program, improves pain, function, pressure pain threshold, muscle strength, psychological status, and quality of life in adults with shoulder tendinopathies. The main questions it aims to answer are: Does the addition of PEMF (SIS) therapy reduce pain intensity and improve pressure pain threshold compared to standard balneophysiotherapy?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Adults aged between 18 and 70 years.
- Patients with chronic shoulder pain lasting more than 3 months, of non-traumatic origin, persistent despite prior conservative treatment.
- Clinical diagnosis of shoulder tendinopathy and/or subacromial pain syndrome based on medical history and physical examination.
- Presence of shoulder pain and functional limitation confirmed by clinical assessment and baseline functional evaluation (SPADI).
- Ability to comply with the treatment protocol and attend scheduled follow-up assessments.
You likely can't join if
- Full-thickness rotator cuff tears with surgical indication.
- Recent major shoulder trauma (within the last 6 months).
- Active systemic inflammatory or rheumatologic diseases.
- Presence of metallic implants in the treatment area or implanted electronic devices (e.g., pacemaker).
- Neurological disorders affecting the upper limb.
- Contraindications to balneotherapy (e.g., severe cardiovascular disease, renal failure, severe dermatological conditions).
See the full eligibility criteria
- Adults aged between 18 and 70 years.
- Patients with chronic shoulder pain lasting more than 3 months, of non-traumatic origin, persistent despite prior conservative treatment.
- Clinical diagnosis of shoulder tendinopathy and/or subacromial pain syndrome based on medical history and physical examination.
- Presence of shoulder pain and functional limitation confirmed by clinical assessment and baseline functional evaluation (SPADI).
- Ability to comply with the treatment protocol and attend scheduled follow-up assessments.
- Provision of written informed consent prior to participation.
- Full-thickness rotator cuff tears with surgical indication.
- Recent major shoulder trauma (within the last 6 months).
- Active systemic inflammatory or rheumatologic diseases.
- Presence of metallic implants in the treatment area or implanted electronic devices (e.g., pacemaker).
- Neurological disorders affecting the upper limb.
- Contraindications to balneotherapy (e.g., severe cardiovascular disease, renal failure, severe dermatological conditions).
- Decompensated chronic diseases at the time of enrollment (cardiovascular, hepatic, renal, respiratory, or neurological).
- Skin lesions at the site of treatment application.
- Pregnancy or breastfeeding.
- Active neoplastic disease.
- Decompensated psychiatric disorders.
- History of hypersensitivity to natural therapeutic factors used in balneotherapy.
- Refusal to participate or inability to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Constanța, Techirghiol, Romania
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Constanța, Techirghiol, Romania. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.